| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9218298 | Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology | 2005 | 7 Pages |
Abstract
The results of this trial indicate that the use of intraoperative dexamethasone is an effective therapeutic strategy for limiting trismus following surgical removal of impacted third molars. The combination of preoperative rofecoxib 50 mg and intraoperative dexamethasone 10 mg was most effective in minimizing pain and trismus following third molar surgery.
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Paul A. DMD, PhD, MPH, Pardeep DMD, Eric R. DMD, Bernard J. DMD, MD,